Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series Analysis.
Arnaud CalliesLise Martin-PercevalLise CrémetLilas GélyAnne-Lise RuellanMarie-Clemence VerdierMatthieu GregoireCyril FlamantAurélie GuillouzouicSonia Prot-LabartheMarine ButinElise LaunayPublished in: The Pediatric infectious disease journal (2023)
Treatment of late-onset neonatal staphylococcal sepsis is sometimes challenging with feared side effects of vancomycin, increasing minimal inhibitory concentrations and questions about catheter management. In case of failure, ceftaroline was administered as a compassionate treatment in 16 infants (gestational age of less than 32 weeks and less than 28 postnatal days), whose first-line treatment failed. We report 11 successes and no severe adverse drug reactions. Larger data are required to confirm these encouraging results.